HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet

Identifying innovative molecules involved in the tumor immune escape process could help refine the survival stratification of colorectal cancer (CRC) patients. HLA-G, a non-classical HLA molecule, physiologically involved in tolerogenic mechanisms, has recently emerged as a relevant prognostic marke...

Descripción completa

Detalles Bibliográficos
Autores principales: Gambella, Alessandro, Scabini, Stefano, Zoppoli, Gabriele, De Silvestri, Annalisa, Pigozzi, Simona, Paudice, Michele, Campora, Michela, Fiocca, Roberto, Grillo, Federica, Mastracci, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726768/
https://www.ncbi.nlm.nih.gov/pubmed/35902421
http://dx.doi.org/10.1007/s00418-022-02141-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726768/
https://www.ncbi.nlm.nih.gov/pubmed/35902421
http://dx.doi.org/10.1007/s00418-022-02141-w

Ejemplares similares